Securities fraud investigation at courthouse

Open Settlements for Investors

Court-approved settlements are in progress. Check if you qualify to claim money.

Total Settlement Funds Currently Available

$750,600,000

Masimo Corporation (MASI)

Settlement Fund: $33,750,000

Claim Deadline: April 28, 2026(Due Today)

Hearing Date: May 5, 2026

Class Period: May 4, 2022 - November 6, 2023

Acadia Healthcare Company, Inc. (ACHC)

Settlement Fund: $179,000,000

Claim Deadline: April 30, 2026(2 Days Left)

Hearing Date: April 29, 2026

Class Period: April 29, 2014 - February 13, 2019

Origin Materials, Inc. (ORGN)

Settlement Fund: $9,000,000

Claim Deadline: May 4, 2026(6 Days Left)

Hearing Date: June 8, 2026

Class Period: March 6, 2023 - November 7, 2023

Snap Inc. (SNAP)

Settlement Fund: $65,000,000

Claim Deadline: May 6, 2026(8 Days Left)

Hearing Date: April 23, 2026

Class Period: February 5, 2021 - January 19, 2022

Hub Cyber Security Ltd. f/k/a Hub Cyber Security (Israel) Ltd. (HUBC)

Settlement Fund: $11,000,000

Claim Deadline: May 13, 2026(15 Days Left)

Hearing Date: June 29, 2026

Class Period: March 1, 2023 - July 31, 2023

Catalent, Inc. (CTLT)

Settlement Fund: $78,000,000

Claim Deadline: May 26, 2026(28 Days Left)

Hearing Date: June 10, 2026

Class Period: August 30, 2021 - August 4, 2023

Fidelity National Information Services, Inc. (FIS)

Settlement Fund: $210,000,000

Claim Deadline: May 28, 2026(30 Days Left)

Hearing Date: July 9, 2026

Class Period: May 7, 2020 - May 12, 2023

GSX Techedu Inc. (GSX)

Settlement Fund: $9,500,000

Claim Deadline: May 30, 2026(32 Days Left)

Hearing Date: June 4, 2026

Class Period: June 6, 2019 - January 15, 2021

Hayward Holdings, Inc. (HAYW)

Settlement Fund: $19,850,000

Claim Deadline: June 19, 2026(52 Days Left)

Hearing Date: May 20, 2026

Class Period: October 26, 2021 - October 25, 2022

Didn't Find Your Settlement?

See ongoing shareholder cases and discover which companies are still under review.

WHAT'S NEW

Active CaseImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update

ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update

ImmunityBio, Inc. (IBRX) faces a class action alleging it misled investors by overstating Anktiva’s cancer treatment potential and approved uses, following an FDA warning letter and stock decline.

Missing Numbers, Broken Trust: What Investors Need to Know

Missing Numbers, Broken Trust: What Investors Need to Know

BREAKING: Wall Street execs shocked to discover that “trust” is not a legal defense. When the numbers go missing, it’s Main Street that pays the price. Know the signs. Know your rights.